Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT02303639

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02303639
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Finland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02303639. Randomized; no masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2017-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias
Acronym
MANTRA-VT
Condition
Ventricular Tachyarrhythmia
Intervention (Procedure)
Radiofrequency catheter ablation
Intervention (Drug)
Antiarrhythmic drug therapy
Lead sponsor
Central Finland Hospital District (class: other)
Collaborator
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02303639
Content hash
1544cc779ed6647d27efb6a947095a8d24520c0e7dc9d6c3e402663781f95e59